Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD, David W. Scott, MBChB, PhD, Diego Villa, MD FRCPC, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Pedro Farinha, MD PhD, Graham W Slack, MD PhD, Don Wilson, MD, R. Petter Tonseth, MD, Joseph M. Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 401.

https://doi.org/10.1182/blood-2019-128722

Published: 2019

Journal Articles

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Phoebe Tsz Man Cheng, BSc,MD, Diego Villa, MD MPH, R. Petter Tonseth, MD, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Don Wilson, MD, Brian Skinnider, MD, Laurie H Sehn, MD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 2845.

https://doi.org/10.1182/blood-2019-122019

Published: 2019

Journal Articles

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Kerry J. Savage, MDMSc, Joseph M. Connors, MD, Diego R Villa, MDMPH, Greg Hapgood, MD, Alina S Gerrie, MD, Tamara N Shenkier, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne, Francois Benard, MD, James Morris, MD, Tom Pickles, MD, Christina Parsons, MD, Don Wilson, MD, Laurie H. Sehn

Blood (2015) 126 (23): 579.

https://doi.org/10.1182/blood.V126.23.579.579

Published: 2015

Journal Articles

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD MPH, Edward L G Hardy, MD FRCPC, Karamjit K Gill, MD FRCPC, Abdulwahab J Al-Tourah, MBChB, FRCPC, Jesse Shustik, MD, Nicol A Macpherson, MDPhDFRCPC,, Adrian Yee, MD FRCPC, Wendy Lam, MD, Kerry J. Savage, MD MSc, Richard Klasa, MD CM, FRCP(C), Diego Villa, MDMPH, Alina S Gerrie, MD, Tamara Shenkier, MD, Graham W Slack, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, Peter Tonseth, MD, Joseph M Connors, MD

Blood (2014) 124 (21): 392.

https://doi.org/10.1182/blood.V124.21.392.392

Published: 2014

Journal Articles

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

Laurie H. Sehn, MD, MPH, Paul Hoskins, MD, Richard Klasa, MD, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, James Morris, MD, Tom Pickles, MD, Joseph M. Connors, MD, Kerry J. Savage, MD

Blood (2010) 116 (21): 854.

https://doi.org/10.1182/blood.V116.21.854.854

Published: 2010

Journal Articles

FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.

Kerry J. Savage, MD, MSc, Joseph M. Connors, MD, Don Wilson, MD, Richard Klasa, MD, Tamara Shenkier, MD, Paul Hoskins, MD, Nicholas Voss, MD, Laurie H. Sehn, MD

Blood (2007) 110 (11): 213.

https://doi.org/10.1182/blood.V110.11.213.213

Published: 2007

Journal Articles

Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.

Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, Paul Hoskins, MD, Richard Klasa, MD, Tamara Shenkier, MD, Nicholas Voss, MD, Don Wilson, MD, Joseph M. Connors, MD

Blood (2007) 110 (11): 787.

https://doi.org/10.1182/blood.V110.11.787.787

Published: 2007

NARROW

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.

Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.

Email alerts

ASH Publications

American Society of Hematology

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.

Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only